Increased seroprevalence and improved antibody responses following third primary SARS-CoV-2 immunisation: an update from the COV-AD study (2022)

First Author: Shields A
Attributed to:  COV-AD: COVID infection in patients with antibody deficiency funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.21203/rs.3.rs-1489715/v1

Publication URI: http://dx.doi.org/10.21203/rs.3.rs-1489715/v1

Type: Preprint